Bruns Ingmar insider trades
Bruns Ingmar has filed 7 Form 4s with the SEC that we hold, for Zentalis Pharmaceuticals, Inc. (ZNTL) (Chief Medical Officer) and TRIL (Chief Medical Officer). Across all of them we count 1 purchase worth $45.6K and 2 sales worth $8.0K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($8.0K). The largest single trade was a purchase of 20,000 shares of Zentalis Pharmaceuticals, Inc. worth $45.6K, dated 2025-02-06. The first filing on our record is dated 2021-11-19 and the latest 2026-10-01.
Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-06 | P, purchase reported on Form 4 | 20,000 | $45.6K | 2025-02-12 |
| 2026-02-06 | S, sale reported on Form 4 | 2,962 | $7.2K | 2026-02-10 |
| 2026-02-09 | S, sale reported on Form 4 | 335 | $801 | 2026-02-10 |
TRIL
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1838041) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms